Published Date: Oct 22 2021
Gene-Biocon had participated in CPHI, from 16 to 18 Dec 2021. Booth no. Hall3, E3E82.
Our focus remained on expanding our Pharmaceutical raw products portfolio. Apart from a wide range of new Recombinant Trypsin, Recombinant Lysyl Endopeptidase, Recombinant Enterokinase and Recombinant Kex2 Protease, we have also exhibited our API Pharmaceutical and Cell growth Factor series, like Insulin Degludec, Insulin Aspart, Liraglutide, Semaglutide, EGF, IGF-1 and bFGF.
And there’s more! So, thank you for your came and joined us at the booth and checked out our exciting range of Pharmaceutical raw products to know more. Hoping you were satisfied with that our sales experts have provided solutions for your customized needs.
